POU2F1 Gene

Aliases
for POU2F1 gene

Previous GC identifers: GC01P164826 GC01P162840 GC01P163886 GC01P164377 GC01P163921 GC01P165456 GC01P138436

Summaries
for POU2F1 gene

Genomic Views
for POU2F1 gene

RefSeq DNA sequence:

NC_000001.10  NC_018912.1  NT_004487.19  

SwitchGear Promoter luciferase reporter plasmid: POU2F1 promoter sequence

QIAGEN PyroMark CpG Assay predesigned Pyrosequencing DNA Methylation assays in human, mouse, rat POU2F1

POU2F1 Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)


GeneLoc information about chromosome 1         GeneLoc Exon Structure

GeneLoc location for GC01P167190:  view genomic region     (about GC identifiers)

Proteins
for POU2F1 gene

6/8 PDB 3D structures from and Proteopedia for POU2F1 (see all 8):

1CQT (3D)        1E3O (3D)        1GT0 (3D)        1HF0 (3D)        1O4X (3D)        1OCT (3D)    

Explore the universe of human proteins at neXtProt for POU2F1: NX_P14859

Post-translational modifications:

	Browse Purified and Recombinant Proteins at EMD Millipore
	Browse R&D Systems for human recombinant proteins
	Browse recombinant and purified proteins available from Enzo Life Sciences
	OriGene Purified Protein: POU2F1 OriGene Protein Over-expression Lysate: POU2F1 OriGene Custom Protein Services for POU2F1
	GenScript Custom Purified and Recombinant Proteins Services for POU2F1
	Novus Biologicals POU2F1 Protein Novus Biologicals POU2F1 Lysates
	Browse Sino Biological Recombinant Proteins
	Browse ProSpec Recombinant Proteins
	Browse Proteins at Uscn

Gene Ontology (GO): 3 cellular component terms (GO ID links to tree view):    About this table

	EMD Millipore Mono- and Polyclonal Antibodies for the study of POU2F1
	R&D Systems Antibodies for POU2F1 (1-Oct)
	Cell Signaling Technology (CST) Antibodies for POU2F1  (1-Oct)
	Browse OriGene Antibodies OriGene Custom Antibody Services for POU2F1
	GenScript Custom Superior Antibodies Services for POU2F1
	Novus Biologicals POU2F1 Antibodies
	Abcam antibodies for POU2F1
	Browse Antibodies at Uscn
	ThermoFisher Antibodies for POU2F1

	Browse Kits and Assays available from EMD Millipore
	OriGene Custom Immunoassay Development Browse OriGene Fluorogenic Cell Assay Kits
	Browse R&D Systems for biochemical assays
	GenScript Custom Assay Services for POU2F1
	Browse Enzo Life Sciences for kits & assays
	Browse ELISAs and CLIAs at Uscn

Protein Domains /
Families
for POU2F1 gene

ProtoNet protein and cluster: P14859

Function
for POU2F1 gene

     Gene Ontology (GO): 4 molecular function terms (GO ID links to tree view):    About this table

(inferred from 3 alleles) (MGI details for Pou2f1)

inGenious Targeting Laboratory - Customizable classic, inducible, and humanized mouse model solutions for POU2F1

		10/2681 SABiosciences Target genes for POU2F1 (see all 2681):
		A1CF A4GNT AAA1 AADAC AARS2 AASDH AASDHPPT AATK ABCA13 ABCB4

miRNA Products:		OriGene 3'-UTR Clone: POU2F1 Browse MicroRNA Expression Plasmids
		QIAGEN Custom miScript Target Protector blocks miRNA-binding site of human, mouse, rat POU2F1
		8/277 QIAGEN miScript miRNA Assays for microRNAs that regulate POU2F1 (see all 277):
		hsa-miR-579 hsa-miR-605 hsa-miR-1273d hsa-miR-3622b-3p hsa-miR-761 hsa-miR-520b hsa-miR-3690 hsa-miR-34c-5p
		SwitchGear 3'UTR luciferase reporter plasmid: POU2F1 3' UTR sequence

Inhib. RNA Products:		Browse for Gene Knock-down Tools from EMD Millipore
		OriGene 29mer shRNA kits in GFP-retroviral vector in human, mouse, rat for POU2F1 (see all 4) OriGene shRNA RFP: POU2F1 OriGene siRNA: POU2F1
		QIAGEN FlexiTube/FlexiPlate siRNA for gene silencing in human, mouse, rat POU2F1
		Sirion Biotech Custom design and validation of potent shRNA sequences against POU2F1

Gene Editing Products:			DNA2.0 Custom Protein Engineering Service for POU2F1
			Sirion Biotech Customized adenovirus for overexpression of POU2F1  Sirion Biotech Customized adenovirus for potent knockdown of POU2F1

Clone Products:		Browse Clones for the Expression of Recombinant Proteins Available from EMD Millipore
		OriGene Myc/DDK tagged cDNA clones in CMV expression vector in human, mouse, rat for POU2F1 (see all 7) OriGene untagged cDNA clones in CMV expression vector in human, mouse, rat for POU2F1 OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
		GenScript: all cDNA clones in your preferred vector (see all 3): POU2F1 (NM_001198783)
		Browse Sino Biological Human cDNA Clones
		DNA2.0 Custom Codon Optimized Gene Synthesis Service for POU2F1
		Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat POU2F1

Cell Line Products:		GenScript Custom overexpressing Cell Line Services for POU2F1
		Search LifeMap BioReagents cell lines for POU2F1
		Sirion Biotech Customized stable knockdown cell line services for POU2F1  Sirion Biotech Customized inducible knockdown cell line services for POU2F1 Sirion Biotech Customized stable overexpressing cell line services for POU2F1 Sirion Biotech Customized inducible overexpressing cell line services for POU2F1

In Situ Assay Products:

Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for POU2F1

Pathways & Interactions
for POU2F1 gene

	Super-pathway	contained gene-specific pathways
1	RNA Polymerase III Transcription Initiation	RNA Polymerase III Abortive And Retractive Initiation 1.00 RNA Polymerase III Transcription Initiation From Type 3 Promoter 0.80 RNA Polymerase III Transcription Initiation 1.00 RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription 0.59 RNA Polymerase III Transcription 1.00
2	Calcium signaling in the CD4+ TCR pathway	Calcium signaling in the CD4+ TCR pathway 1.00 Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.38
3	Immune response_IL-2 activation and signaling pathway	Immune response IL-3 activation and signaling pathway 0.41 Immune response_IL-3 activation and signaling pathway 0.41
4	Mechanisms of CFTR activation by S-nitrosoglutathione (normal and CF)	Development Glucocorticoid receptor signaling 0.27 Development_Glucocorticoid receptor signaling 0.27
5	Transcription	Transcription 1.00

2 EMD Millipore Pathways for POU2F1

	Development Glucocorticoid receptor signaling
	Immune response IL-3 activation and signaling pathway

3 Downloadable PowerPoint Slides of QIAGEN Pathway Central Maps for POU2F1

	BRCA1 Pathway
	Glucocorticoid Receptor Signaling
	PKC-Theta Pathway

2 GeneGo (Thomson Reuters) Pathways for POU2F1

	Immune response IL-3 activation and signaling pathway
	Development Glucocorticoid receptor signaling

5/6 BioSystems Pathways for POU2F1

	Regulation of Androgen receptor activity
	FOXA1 transcription factor network
	Calcineurin-regulated NFAT-dependent transcription in lymphocytes
	Calcium signaling in the CD4+ TCR pathway
	Glucocorticoid receptor regulatory network

5/7        Reactome Pathways for POU2F1

	RNA Polymerase III Transcription Initiation
	RNA Polymerase III Transcription Initiation From Type 3 Promoter
	Transcription
	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
	RNA Polymerase III Transcription

Gene Ontology (GO): 5/7 biological process terms (GO ID links to tree view) (see all 7):    About this table

Drugs & Compounds
for POU2F1 gene

Transcripts
for POU2F1 gene

Expression
for POU2F1 gene

POU2F1 expression in normal human tissues (normalized intensities)
See probesets specificity/sensitivity at GeneAnnot
About this imageBioGPS
CGAP TAG: GATTGGAGAA

About this image
See POU2F1 Protein Expression from SPIRE MOPED and PaxDB
Genevestigator expression for POU2F1

SOURCE GeneReport for Unigene cluster: Hs.283402

Primer Products:		OriGene genome-wide validated SYBR primer pairs in human, mouse, rat for POU2F1 Browse OriGene validated miRNA SYBR primer pairs
		SABiosciences RT2 qPCR Primer Assay in human, mouse, rat POU2F1
		QIAGEN QuantiTect SYBR Green Assays in human, mouse, rat POU2F1
		QIAGEN QuantiFast Probe-based Assays in human, mouse, rat POU2F1

In Situ Assay Products:

Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for POU2F1

Orthologs
for POU2F1 gene

Paralogs
for POU2F1 gene

Paralogs for POU2F1 gene

POU5F2²  POU6F2²  POU4F2²  POU2F3²  POU3F4²  POU3F1²  POU1F1²  POU4F3²  

POU3F3²  POU3F2²  POU2F2²  POU5F1B²  POU4F1²  POU5F1²  POU6F1²  

16 SIMAP similar genes for POU2F1 using alignment to 8 protein entries:     PO2F1_HUMAN (see all proteins):

OCT6    OCT-2    POU3F1    POU6F1    POU2F3    POU2F2

POU1F1    POU5F1P4    POU3F4    POU5F1    NKX2-5    POU3F2

POU4F3    POU5F1B    POU5F1P1    POU3F3

POU2F1 for paralogs           About GeneDecksing

Genomic Variants
for POU2F1 gene

10/3343 NCBI SNPs in POU2F1 are shown (see all 3343)     About this table

Genomic Data					Transcription Related Data				Allele Frequencies
SNP ID	Valid	Clinical significance	Chr 1 pos	Sequence	#	AA Chg	Type	More	#	Allele freq	Pop	Total sample	More
-1st2nd3rd	-1st2nd3rd	-1st2nd3rd	-1st2nd3rd	--	--	--	-1st2nd3rd	--	--	-1st2nd3rd	-1st2nd3rd	-1st2nd3rd
rs356172531,2	C	--	138599368(+)	TTTAA-/TTTTTT	1	--	int1		2		NA CSA	4
rs1877466391,2		--	167188212(+)	ACACAC/TACACT	3	--	us2k1		0	--	--	--	--
rs1437566231,2		--	167188269(+)	AAAGAA/GCAAAA	3	--	us2k1		0	--	--	--	--
rs1142291361,2	F	--	167188585(+)	TACCAC/AGAACA	3	--	us2k1		1		NA	120
rs14978611,2	C,F,H	--	167188630(-)	AAGCTA/GTTGTC	3	--	us2k1		9		MN NS EA NA WA	1006
rs1928852621,2		--	167188644(+)	CTGTAC/TTTGCA	3	--	us2k1		0	--	--	--	--
rs1410846281,2		--	167188660(+)	AAAGGA/GGTCCA	3	--	us2k1		0	--	--	--	--
rs1848948991,2		--	167188790(+)	TATCTC/GTCAAG	3	--	us2k1		0	--	--	--	--
rs1889697171,2		--	167188886(+)	AAATAA/GGGCTT	3	--	us2k1		0	--	--	--	--
rs1501948131,2		--	167188992(+)	GAAAGA/GTATGT	3	--	us2k1		0	--	--	--	--

HapMap Linkage Disequilibrium report for POU2F1 (167190066 - 167396582 bp)
Structural Variations (Copy Number Variations, Insertions/Deletions, Inversions)
Database of Genomic Variants (DGV): 3 variations for POU2F1
     2 CNVs: 34731 84641
     1 Indel: 74769

SABiosciences Cancer Mutation PCR Assays

QIAGEN SeqTarget long-range PCR primers in human, mouse, rat for resequencing POU2F1

DNA2.0 Custom Variant and Variant Library Synthesis for POU2F1

Disorders / Diseases
for POU2F1 gene

20/45 diseases for POU2F1

10/19 Novoseek disease relationships for POU2F1 gene (see all 19)    About this table

Publications
for POU2F1 gene

PubMed articles for POU2F1 gene, integrated from 9 sources (see all 380) (see top 10): (articles sorted by number of sources associating them with POU2F1)

Utopia: connect your pdf to the dynamic world of online information

1. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. (PubMed id 1684878)^{1, 2, 9} Segil N....Heintz N. (1991)
2. Down-regulation of histone H2B by DNA-dependent protein kinase in response to DNA damage through modulation of octamer transcription factor 1. (PubMed id 14612514)^{1, 2, 9} Schild-Poulter C.... Hache R.J.G. (2003)
3. Differential phosphorylation of the transcription factor Oct1 during the cell cycle. (PubMed id 1887216)^{1, 3, 9} Roberts S.B....Heintz N. (1991)
4. Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. (PubMed id 12663137)^{1, 2, 9} Luchina N.N.... Pankratova E.V. (2003)
5. The DNA sequence and biological annotation of human chromosome 1. (PubMed id 16710414)^{1, 2} Gregory S.G.... Bentley D.R. (2006)
6. Identification of hippocampus-related candidate genes for Alzheimer's disease. (PubMed id 15786443)^{1, 4} Taguchi K....Miki T. (2005)
7. Complete sequencing and characterization of 21,243 full-length human cDNAs. (PubMed id 14702039)^{1, 2} Ota T.... Sugano S. (2004)
8. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)^{1, 2} Gerhard D.S....Malek J. (2004)
9. Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP. (PubMed id 10629049)^{1, 2} Mahajan S.S. and Wilson A.C. (2000)
10. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter. (PubMed id 10480874)^{1, 2} Prefontaine G.G....Hache R.J.G. (1999)
11. Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics. (PubMed id 7663141)^{1, 2} Cox M.... Kaptein R. (1995)
12. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. (PubMed id 8156594)^{1, 2} Klemm J.D.... Pabo C.O. (1994)
13. Solution structure of the POU-specific DNA-binding domain of Oct-1. (PubMed id 8479524)^{1, 2} Dekker N....Kaptein R. (1993)
14. The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DNA-binding domain. (PubMed id 8462099)^{1, 2} Assa-Munt N.... Wright P.E. (1993)
15. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. (PubMed id 2905684)^{1, 2} Sturm R.A.... Herr W. (1988)
16. Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter. (PubMed id 7642649)^{1, 9} Nakshatri H....Currie R.A. (1995)
17. A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress. (PubMed id 19171782)^{1, 9} Kang J....Tantin D. (2009)
18. Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor. (PubMed id 11134019)^{1, 9} Kakizawa T....Hashizume K. (2001)
19. Chromosomal structure and expression of the human OTF 1 locus encoding the Oct-1 protein. (PubMed id 8314572)^{1, 9} Sturm R.A....Evans G.A. (1993)
20. Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions. (PubMed id 19058140)^{1, 9} Jariwala U....Coetzee G.A. (2009)
21. A far-upstream Oct-1 motif regulates cytokine-induced transcription of the human inducible nitric oxide synthase gene. (PubMed id 19467240)^{1, 9} Park K.S....Geller D.A. (2009)
22. Oct-1 induces pituitary tumor transforming gene expression in endocrine tumors. (PubMed id 18550719)^{1, 9} Zhou C....Melmed S. (2008)
23. Oct-1 is involved in the transcriptional repression of the p15(INK4b) gene. (PubMed id 17316622)^{1, 9} Hitomi T....Sakai T. (2007)
24. Functional interaction between Oct-1 and retinoid X receptor. (PubMed id 10383413)^{1, 9} Kakizawa T....Hashizume K. (1999)
25. Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1. (PubMed id 17192276)^{1, 9} dela Paz N.G....Collins T. (2007)
26. The regulation of the Oct-1 gene transcription is mediated by two promoters. (PubMed id 12853155)^{1, 9} Pankratova E.V....Krivega I.V. (2003)
27. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. (PubMed id 11777930)^{1, 9} Fan W....Zhan Q. (2002)
28. Insulin stimulates the expression of carbohydrate res ponse element binding protein (ChREBP) by attenuating the repressive effect of Pit-1, Oct-1/Oct-2, and Unc-86 homeodomain protein octamer transcription factor -1. (PubMed id 19359385)^{1, 9} Sirek A.S....Jin T. (2009)
29. LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. (PubMed id 18390905)^{1, 9} Thum T. and Borlak J. (2008)
30. T-13910 DNA variant associated with lactase persistence interacts with Oct-1 and stimulates lactase promoter activity in vitro. (PubMed id 16301215)^{1, 9} Lewinsky R.H....Troelsen J.T. (2005)
31. Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter. (PubMed id 15105429)^{1, 9} Osborne A.R....Blanck G. (2004)
32. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells. (PubMed id 12144930)^{1, 9} Ortego M....Egido J. (2002)
33. Involvement of Oct-1 in the regulation of CDKN1A in response to clinically relevant doses of ionizing radiation. (PubMed id 19118657)^{1, 9} Nenoi M....Kakimoto A. (2009)
34. Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter. (PubMed id 16116232)^{1, 9} Voleti B. and Agrawal A. (2005)
35. STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. (PubMed id 14645506)^{1, 9} Magne S....Dusanter-Fourt I. (2003)
36. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. (PubMed id 12391146)^{1, 9} Boulon S....Philips A. (2002)
37. Octamer transcription factor-1 enhances hepatic nuclear factor- 1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. (PubMed id 10779377)^{1, 9} Ishii Y.... Mackenzie P.I. (2000)
38. The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression. (PubMed id 8668525)^{1, 9} Strom A.C....Westin G. (1996)
39. Octamer-binding transcription factor-1 gene is upregulated in primary varicose veins. (PubMed id 18083338)^{1, 9} Jeong G.A....Chang J.H. (2008)
40. Oct-1 is involved in the transcriptional repression of the gonadotropin-releasing hormone receptor gene. (PubMed id 12446597)^{1, 9} Cheng C.K....Leung P.C. (2002)
41. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. (PubMed id 9537509)^{1, 9} Nie J....Taniguchi T. (1998)
42. Enhanced activation of the human histone H2B promoter by an Oct-1 variant generated by alternative splicing. (PubMed id 8227066)^{1, 9} Das G. and Herr W. (1993)
43. The Groucho-related gene family regulates the gonadotropin-releasing hormone gene through interaction with the homeodomain proteins MSX1 and OCT1. (PubMed id 16002402)^{1, 9} Rave-Harel N....Mellon P.L. (2005)
44. HCF-dependent nuclear import of VP16. (PubMed id 9889203)^{1, 9} La Boissiere S....O'Hare P. (1999)
45. The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1. (PubMed id 9418884)^{1, 9} Wong M.W.... Hernandez N. (1998)
46. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells. (PubMed id 7945330)^{1, 9} Rosfjord E. and Rizzino A. (1994)
47. The gene for the ubiquitous octamer-binding protein Oct-1 is on human chromosome 1, region cen-q32, and near Ly-22 and Ltw-4 on mouse chromosome 1. (PubMed id 2341156)^{1, 9} Hsieh C.L....Francke U. (1990)
48. High-mobility group protein HMGB2 regulates human ery throid differentiation through trans-activation of GFI1B transcription. (PubMed id 19965638)^{1, 9} Laurent B....DumAcnil D. (2010)
49. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. (PubMed id 19070619)^{1, 9} Lim K. and Chang H.I. (2009)
50. Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status. (PubMed id 18682386)^{1, 9} Dai R.P....Luo Y. (2008)
51. GATA-1 and Oct-1 are required for expression of the human alpha-hemoglobin-stabilizing protein gene. (PubMed id 16186125)^{1, 9} Gallagher P.G....Bodine D.M. (2005)
52. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. (PubMed id 12826401)^{2, 9} Wysocka J. and Herr W. (2003)
53. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. (PubMed id 12887926)^{1, 9} Zheng L.... Luo Y. (2003)
54. Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors. (PubMed id 11891224)^{1, 9} Gonzalez M.M. and Carlberg C. (2002)
55. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. (PubMed id 12019209)^{1, 9} van Heel D.A....Kwiatkowski D. (2002)
56. Expression of the Oct-1 transcription factor and characterization of its interactions with the Bob1 coactivator. (PubMed id 11380252)^{1, 9} Lee L....Luisi B. (2001)
57. Gadd45a transcriptional induction elicited by the Auro ra kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 trans cription factor. (PubMed id 22521726)¹ Mancini M....Santucci M.A. (2012)
58. A census of human soluble protein complexes. (PubMed id 22939629)¹ Havugimana P.C....Emili A. (2012)
59. Oct-1 cooperates with the TATA binding initiation comp lex to control rapid transcription of human iNOS. (PubMed id 22349263)¹ Reveneau S....Pance A. (2012)
60. Interplay between minor and major groove-binding trans cription factors Sox2 and Oct1 in translocation on DNA studied by paramagnetic a nd diamagnetic NMR. (PubMed id 22396547)¹ Takayama Y. and Clore G.M. (2012)
61. Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1. (PubMed id 22310390)¹ Lin B.R. and Natarajan V. (2012)
62. Oct1 regulates cell growth of LNCaP cells and is a pr ognostic factor for prostate cancer. (PubMed id 21387309)¹ Obinata D....Inoue S. (2012)
63. Oncosecretomics coupled to bioenergetics identifies a- amino adipic acid, isoleucine and GABA as potential biomarkers of cancer: Differ ential expression of c-Myc, Oct1 and KLF4 coordinates metabolic changes. (PubMed id 22842522)¹ Bellance N....Nagrath D. (2012)
64. Oct-1 acts as a transcriptional repressor on the C-rea ctive protein promoter. (PubMed id 22750226)¹ Voleti B....Agrawal A. (2012)
65. Initial characterization of the human central proteome. (PubMed id 21269460)² Burkard T.R.... Colinge J. (2011)
66. Arterial flow reduces oxidative stress via an antioxi dant response element and Oct-1 binding site within the NADPH oxidase 4 promote r in endothelial cells. (PubMed id 21399967)¹ Goettsch C....Morawietz H. (2011)
67. Reactive oxygen species downregulate catalase express ion via methylation of a CpG island in the Oct-1 promoter. (PubMed id 21985966)¹ Quan X....Jung G. (2011)
68. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. (PubMed id 21406692)² Rigbolt K.T....Blagoev B. (2011)
69. OCT1 Expression in adipocytes could contribute to inc reased metformin action in obese subjects. (PubMed id 20956498)¹ Moreno-Navarrete J.M....FernA!ndez-Real J.M. (2011)
70. Genetically polymorphic OCT1: another piece in the pu zzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic d rug tramadol. (PubMed id 21562485)¹ Tzvetkov M.V....BrockmAPller J. (2011)
71. Cellular transcription factor Oct-1 interacts with th e Epstein-Barr virus BRLF1 protein to promote disruption of viral latency. (PubMed id 21697476)¹ Robinson A.R....Kenney S.C. (2011)
72. Purification and identification of endogenous polySUMO conjugates. (PubMed id 21252943)¹ Bruderer R....Hay R.T. (2011)
73. Replication stress induces 53BP1-containing OPT domai ns in G1 cells. (PubMed id 21444690)¹ Harrigan J.A....Jackson S.P. (2011)
74. Interactions of pathological hallmark proteins: tubul in polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. (PubMed id 21832049)¹ OlA!h J....OvA!di J. (2011)
75. Intra- and intermolecular translocation of the bi-dom ain transcription factor Oct1 characterized by liquid crystal and paramagnetic NMR. (PubMed id 21555551)¹ Takayama Y. and Clore G.M. (2011)
76. Allele-specific transcription of the asthma-associate d PHD finger protein 11 gene (PHF11) modulated by octamer-binding transcription factor 1 (Oct-1). (PubMed id 21320718)¹ Holt R.J....Moffatt M.F. (2011)
77. Systematic and quantitative assessment of the ubiquiti n-modified proteome. (PubMed id 21906983)¹ Kim W....Gygi S.P. (2011)
78. Dynamic regulation of Oct1 during mitosis by phosphor ylation and ubiquitination. (PubMed id 21897860)¹ Kang J....Tantin D. (2011)
79. Correlation between genetic polymorphisms of the hOCT 1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia. (PubMed id 21185600)¹ Maffioli M....Cervantes F. (2011)
80. OCT-1 function varies with cell lineage but is not in fluenced by BCR-ABL. (PubMed id 20971815)¹ Engler J.R....White D.L. (2011)
81. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. (PubMed id 20379614)¹ Rose J.E....Uhl G.R. (2010)
82. Interaction between polymorphisms in the OCT1 and MAT E1 transporter and metformin response. (PubMed id 19898263)¹ Becker M.L....Stricker B.H. (2010)
83. Facilitated DNA search by multidomain transcription f actors: cross talk via a flexible linker. (PubMed id 20713004)¹ Vuzman D....Levy Y. (2010)
84. Association of the POU class 2 homeobox 1 gene (POU2F 1) with susceptibility to Type 2 diabetes in Chinese populations. (PubMed id 21059098)¹ Ng M.C....Chan J.C. (2010)
85. An atlas of combinatorial transcriptional regulation in mouse and man. (PubMed id 20211142)¹ Ravasi T....Hayashizaki Y. (2010)
86. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. (PubMed id 20068231)² Olsen J.V....Mann M. (2010)
87. Molecular reclassification of Crohn's disease by clus ter analysis of genetic variants. (PubMed id 20886065)¹ Cleynen I....Vermeire S. (2010)
88. Oct-1 is responsible for the C-33T polymorphism effec t in the IL-4 promoter. (PubMed id 19804407)¹ Gervaziev Y.V....Gervazieva V.B. (2010)
89. New genetic associations detected in a host response study to hepatitis B vaccine. (PubMed id 20237496)¹ Davila S....Seielstad M. (2010)
90. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. (PubMed id 20215511)¹ Harte M.T....Harkin D.P. (2010)
91. Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. (PubMed id 20921968)¹ Tzvetkov M.V....BrockmAPller J. (2010)
92. Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus seque nce. (PubMed id 19327156)¹ Xu X.S....Wang G. (2009)
93. Genetic Risk Profiling And Prediction Of Disease Course In Crohn'S Disease Patients. (PubMed id 19422935)¹ Henckaerts L....Vermeire S. (2009)
94. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. (PubMed id 19174780)¹ Weersma R.K....Vermeire S. (2009)
95. POU homeodomain protein Oct-1 functions as a sensor f or cyclic AMP. (PubMed id 19617623)¹ Wang P....Jin T. (2009)
96. Pre-B-cell leukemia homeobox 1 (PBX1) shows functional and possible genetic association with bone mineral density variation. (PubMed id 19064610)¹ Cheung C.L....Kung A.W. (2009)
97. Histone acetylation characterizes chromatin presettin g by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV prom oter. (PubMed id 19463811)¹ Astrand C....Wrange O. (2009)
98. Follow-up of a major linkage peak on chromosome 1 rev eals suggestive QTLs associated with essential hypertension: GenNet study. (PubMed id 19536175)¹ Ehret G.B....Chakravarti A. (2009)
99. Coeliac disease associated risk variants in TNFAIP3 and REL implicate altered NF-{kappa}B signalling. (PubMed id 19240061)¹ Trynka G....Wijmenga C. (2009)
100. Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone. (PubMed id 18599544)¹ Zhao W....Cardozo C.P. (2008)
101. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. (PubMed id 18030470)¹ Kitada N....Yokoyama T. (2008)
102. A quantitative atlas of mitotic phosphorylation. (PubMed id 18669648)² Dephoure N.... Gygi S.P. (2008)
103. Analysis of the transcriptional regulation of the FABP2 promoter haplotypes by PPARgamma/RXRalpha and Oct-1. (PubMed id 18634911)¹ Bohme M....Klapper M. (2008)
104. Global jumping and domain-specific intersegment transfer between DNA cognate sites of the multidomain transcription factor Oct-1. (PubMed id 18772384)¹ Doucleff M. and Clore G.M. (2008)
105. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. (PubMed id 18940312)¹ Yuan X....Mooser V. (2008)
106. Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: Transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer. (PubMed id 17273778)¹ Katoh Y. and Katoh M. (2007)
107. Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells. (PubMed id 17442950)¹ Mummidi S....Ahuja S.K. (2007)
108. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. (PubMed id 18000219)¹ Hosey A.M....Harkin D.P. (2007)
109. DNA-PK phosphorylation sites on Oct-1 promote cell su rvival following DNA damage. (PubMed id 17213819)¹ Schild-Poulter C....HachAc R.J. (2007)
110. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. (PubMed id 16344560)¹ Kimura K.... Sugano S. (2006)
111. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. (PubMed id 16964243)² Beausoleil S.A.... Gygi S.P. (2006)
112. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line. (PubMed id 16360016)¹ Osborne A.R....Blanck G. (2006)
113. The consensus coding sequences of human breast and colorectal cancers. (PubMed id 16959974)² Sjoeblom T.... Velculescu V.E. (2006)
114. Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. (PubMed id 16025120)¹ Bertolino E....Singh H. (2005)
115. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice. (PubMed id 15613485)¹ Liu L.R....Zhang J.W. (2005)
116. Silencing of Fshr occurs through a conserved, hypersensitive site in the first intron. (PubMed id 15817654)¹ Hermann B.P. and Heckert L.L. (2005)
117. Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP. (PubMed id 15831936)¹ Almqvist J....Ernberg I. (2005)
118. TALE homeodomain proteins regulate gonadotropin-releasing hormone gene expression independently and via interactions with Oct-1. (PubMed id 15138251)¹ Rave-Harel N....Mellon P.L. (2004)
119. Large-scale characterization of HeLa cell nuclear phosphoproteins. (PubMed id 15302935)¹ Beausoleil S.A....Gygi S.P. (2004)
120. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid). (PubMed id 15207707)¹ Zhao H....Jiang L. (2004)
121. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. (PubMed id 14559893)¹ Williams D.C....Clore G.M. (2004)
122. OBF1 enhances transcriptional potential of Oct1. (PubMed id 12727885)¹ Lins K....Scholer H.R. (2003)
123. Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell- proliferation factor HCF-1. (PubMed id 12670868)¹ Wysocka J.... Herr W. (2003)
124. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. (PubMed id 14586402)¹ Hirose T....Sakai T. (2003)
125. Selective inhibition of class switching to IgG and IgE by recruitment of the HoxC4 and Oct-1 homeodomain proteins and Ku70/Ku86 to newly identified ATTT cis-elements. (PubMed id 12672812)¹ Schaffer A....Casali P. (2003)
126. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. (PubMed id 12923055)¹ Remenyi A....Wilmanns M. (2003)
127. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. (PubMed id 12598320)¹ Marafioti T....Pileri S.A. (2003)
128. Gene switching by metabolic enzymes--how did you get on the invitation list? (PubMed id 12887915)¹ McKnight S. (2003)
129. [Regulation of human oct-1 gene transcription involves two promotors] (PubMed id 12669425)¹ Zhenilo S.V....Polianovskii O.L. (2003)
130. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. (PubMed id 14522952)¹ Lerner L....Darnell J.E. (2003)
131. Ku antigen, an origin-specific binding protein that associates with replication proteins, is required for mammalian DNA replication. (PubMed id 12393188)¹ Matheos D....Zannis-Hadjopoulos M. (2002)
132. Crystallization of the Oct-1/SNAP190 peptide/DNA complex. (PubMed id 11856838)¹ Hovde S....Geiger J.H. (2002)
133. Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct. (PubMed id 11997177)¹ Gonzalez M.I....Robins D.M. (2002)
134. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)¹ Strausberg R.L....Marra M.A. (2002)
135. Oct-1 preferentially interacts with androgen receptor in a DNA-dependent manner that facilitates recruitment of SRC-1. (PubMed id 11096094)¹ Gonzalez M.I. and Robins D.M. (2001)
136. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. (PubMed id 11583619)¹ Remenyi A....Wilmanns M. (2001)
137. A map of protein-protein contacts within the small nuclear RNA- activating protein complex SNAPc. (PubMed id 11056176)¹ Ma B. and Hernandez N. (2001)
138. The binding of Ku antigen to homeodomain proteins promotes their phosphorylation by DNA-dependent protein kinase. (PubMed id 11279128)¹ Schild-Poulter C....Hache R.J. (2001)
139. A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. (PubMed id 10976766)¹ Gunther M....Brison O. (2000)
140. Developmental effects of ectopic expression of the glucocorticoid receptor DNA binding domain are alleviated by an amino acid substitution that interferes with homeodomain binding. (PubMed id 10490647)¹ Wang J.M....Hache R.J. (1999)
141. Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface. (PubMed id 10541551)¹ Chasman D....Pabo C.O. (1999)
142. Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix. (PubMed id 9525610)¹ Angeletti P.C. and Engler J.A. (1998)
143. Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. (PubMed id 9584182)¹ Prefontaine G.G....Hache R.J. (1998)
144. High mobility group I/Y protein functions as a specif ic cofactor for Oct-2A: mapping of interaction domains. (PubMed id 9823775)¹ Abdulkadir S.A....Ono S.J. (1998)
145. Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. (PubMed id 9242494)¹ Andersen B....Rosenfeld M.G. (1997)
146. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. (PubMed id 9368058)¹ Inamoto S....Roeder R.G. (1997)
147. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. (PubMed id 7720710)¹ Zwilling S....Wirth T. (1995)
148. The human OTF1 locus which overlaps the CD3Z gene is located at 1q22-->q23. (PubMed id 7842742)¹ Sturm R.A....Sutherland G.R. (1995)
149. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP. (PubMed id 8202368)¹ Zwilling S....Wirth T. (1994)
150. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. (PubMed id 7690421)¹ Jeang K.T....Fan H. (1993)
151. Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16). (PubMed id 8454622)¹ Kristie T.M. and Sharp P.A. (1993)
152. Characterization of an Oct1 orthologue in the channel catfish, Ictalurus punctatus: a negative regulator of immunoglobulin gene transcription? (PubMed id 17266766)⁹ Lennard M.L....Warr G.W. (2007)
153. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. (PubMed id 8422989)⁹ Cleary M.A....Herr W. (1993)
154. Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2. (PubMed id 8441632)⁹ Suzuki N....Scholer H.R. (1993)
155. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. (PubMed id 16278805)⁹ Almeida R....David L. (2005)
156. Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells. (PubMed id 9489510)⁹ Liu X.K....Andrawis N.S. (1998)
157. Cloning, sequencing and expression of two isoforms of the murine oct-1 transcription factor. (PubMed id 7711063)⁹ Jaffe J....Laskov R. (1995)
158. [Alternative promoters and oct-1 gene tissue-specific regulation] (PubMed id 16358731)⁹ (2005)
159. Oct-1 enhances the in vitro replication of a mammalia n autonomously replicating DNA sequence. (PubMed id 9518258)⁹ Matheos D.D....Zannis-Hadjopoulos M. (1998)
160. Dissociation of Oct-1 from the nuclear peripheral structure induces the cellular aging-associated collagenase gene expression. (PubMed id 9398664)⁹ Imai S....Takano T. (1997)
161. Characterization of a trimeric complex containing Oct -1, SNAPc, and DNA. (PubMed id 9188510)⁹ Ford E. and Hernandez N. (1997)
162. Oct-1 [corrected] and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases. (PubMed id 8645173)⁹ Grenfell S.J....Thomas N.S. (1996)
163. Repression of the human papillomavirus type 18 enhanc er by the cellular transcription factor Oct-1. (PubMed id 1654457)⁹ Hoppe-Seyler F....zur Hausen H. (1991)
164. Characterization of a cellular factor which interacts functionally with Oct-1 in the assembly of a multicomponent transcription complex. (PubMed id 2175881)⁹ Katan M....O'Hare P. (1990)
165. Cloning, genomic organization, expression, and effect on beta-casein promoter activity of a novel isoform of the mouse Oct-1 transcription factor. (PubMed id 14729276)⁹ Zhao F.Q....Oka T. (2004)
166. NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication. (PubMed id 15576348)⁹ Mysiak M.E....van der Vliet P.C. (2004)
167. POU domain factors in neural development. (PubMed id 10026784)⁹ Schonemann M.D....Rosenfeld M.G. (1998)
168. Non-cell autonomous induction of apoptosis and loss of posterior structures by activation domain-specific interactions of Oct-1 in the Xenopus embryo. (PubMed id 10200537)⁹ Veenstra G.J....Destree O.H. (1998)
169. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. (PubMed id 8157005)⁹ Pfisterer P....Wirth T. (1994)
170. Convergent regulation of NF-IL6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. (PubMed id 8455626)⁹ Hsu W. and Chen-Kiang S. (1993)
171. Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters. (PubMed id 2123291)⁹ Pierani A....Roeder R.G. (1990)
172. BOB.1 of the channel catfish, Ictalurus punctatus: not a transcriptional coactivator? (PubMed id 19041136)⁹ Richard M.L....Warr G.W. (2009)
173. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells. (PubMed id 19118563)⁹ Turner E.C. and Kinsella B.T. (2009)
174. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation. (PubMed id 17537858)⁹ Carroll K.D....Lukac D.M. (2007)
175. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression. (PubMed id 16186795)⁹ Heckman C.A....Boxer L.M. (2006)
176. Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter. (PubMed id 15885880)⁹ Brockman J.L. and Schuler L.A. (2005)
177. Regulation of oct-1 gene transcription is different in lymphoid and non-lymphoid cells. (PubMed id 14505828)⁹ Zhenilo S....Polanovsky O. (2003)
178. Unique function for carboxyl-terminal domain of Oct-2 in Ig-secreting cells. (PubMed id 11591767)⁹ Sharif M.N....Eckhardt L.A. (2001)
179. A positioned nucleosome on the human U6 promoter allows recruitment of SNAPc by the Oct-1 POU domain. (PubMed id 11463379)⁹ Zhao X....Hernandez N. (2001)
180. Herpes simplex virus transactivator VP16 discriminates between HCF-1 and a novel family member, HCF-2. (PubMed id 10196288)⁹ Johnson K.M.... Wilson A.C. (1999)
181. Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression. (PubMed id 10437913)⁹ Zhang H....Blanck G. (1999)
182. Maximization of selenocysteine tRNA and U6 small nuclear RNA transcriptional activation achieved by flexible utilization of a Staf zinc finger. (PubMed id 10455183)⁹ Schaub M....Carbon P. (1999)
183. Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. (PubMed id 9722596)⁹ Subramaniam N....Okret S. (1998)
184. Coactivation by OCA-B: definition of critical regions and synergism with general cofactors. (PubMed id 9632764)⁹ Luo Y....Roeder R.G. (1998)
185. The Oct-1 POU homeodomain stabilizes the adenovirus p reinitiation complex via a direct interaction with the priming protein and is d isplaced when the replication fork passes. (PubMed id 9013582)⁹ van Leeuwen H.C....van der Vliet P.C. (1997)
186. Analysis of homeodomain function by structure-based design of a transcription factor. (PubMed id 7568211)⁹ Pomerantz J.L....Sharp P.A. (1995)
187. Reduced level of octamer binding transcription factor (Oct-1) is correlated with H2B histone gene repression during differentiation of HL-60 cells by all-trans retinoic acid. (PubMed id 7646519)⁹ Kim K.Y....Lim K. (1995)
188. The adenovirus DNA binding protein effects the kinetics of DNA replication by a mechanism distinct from NFI or Oct-1. (PubMed id 8441675)⁹ Mul Y.M. and van der Vliet P.C. (1993)
189. The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. (PubMed id 1684335)⁹ Stern S. and Herr W. (1991)
190. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. (PubMed id 2216722)⁹ Schreiber E....Fontana A. (1990)
191. Tethered-hopping model for protein-DNA binding and un binding based on Sox2-Oct1-Hoxb1 ternary complex simulations. (PubMed id 20371328)⁹ Lian P....Wei D. (2010)
192. Functional characterization of a promoter polymorphis m in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. (PubMed id 19541747)⁹ Lu J....Lu D. (2009)
193. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. (PubMed id 16173915)⁹ Chen J....Mehta J.L. (2006)
194. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. (PubMed id 16648862)⁹ McCune R.C....Vasef M.A. (2006)
195. Autoregulation of Oct-1 gene expression is mediated by two octa-sites in alternative promoter. (PubMed id 16716485)⁹ Pankratova E....Polanovsky O. (2006)
196. Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein. (PubMed id 15798204)⁹ Inman C.K....Shore P. (2005)
197. DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho/TLE. (PubMed id 16103132)⁹ Malin S....Pettersson S. (2005)
198. Overexpression of octamer transcription factors 1 or 2 alone has no effect on HIV-1 transcription in primary human CD4 T cells. (PubMed id 15051391)⁹ Zhang M....Cron R.Q. (2004)
199. Phylogenetic footprinting reveals evolutionarily conserved regions of the gonadotropin-releasing hormone gene that enhance cell-specific expression. (PubMed id 15319450)⁹ Givens M.L....Mellon P.L. (2004)
200. A novel transcriptional element which regulates expression of the CYP2D4 gene by Oct-1 and YY-1 binding. (PubMed id 12818430)⁹ Mizuno D....Funae Y. (2003)
201. Regulation of human FcepsilonRI beta chain gene expression by Oct- 1. (PubMed id 12697656)⁹ Akizawa Y.... Ogawa H. (2003)
202. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation. (PubMed id 11221850)⁹ Takahashi S....Sakai T. (2001)
203. Oct-1 specifically binds the UEF4 site of the human AP1-regulated urokinase enhancer. (PubMed id 10951201)⁹ Palazzolo M....Blasi F. (2000)
204. Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. Roles of the oct-1 el ement in the 5'-flanking region and the AP-2 element in the untranslated exon 1 . (PubMed id 10998423)⁹ Fujimori K....Urade Y. (2000)
205. The Oct-1 POU domain activates snRNA gene transcripti on by contacting a region in the SNAPc largest subunit that bears sequence simi larities to the Oct-1 coactivator OBF-1. (PubMed id 9832505)⁹ Ford E....Hernandez N. (1998)
206. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. (PubMed id 8999951)⁹ Wu G.D....Wen X. (1997)
207. Differential in vivo activation of the class II and c lass III snRNA genes by the POU-specific domain of Oct-1. (PubMed id 9153304)⁹ Murphy S. (1997)
208. Abnormality of Oct-1 DNA binding in T cells from Sjogren's syndrome patients. (PubMed id 8814238)⁹ Flescher E....Talal N. (1996)
209. A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine -rich domain. (PubMed id 8754837)⁹ Kim M.K....Chung J.H. (1996)
210. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. (PubMed id 7871754)⁹ O'Connor M. and Bernard H.U. (1995)
211. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain. (PubMed id 7891704)⁹ Cleary M.A. and Herr W. (1995)
212. In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts. (PubMed id 8502621)⁹ Thomson J.A....Sturm R.A. (1993)
213. Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. (PubMed id 1535687)⁹ Murphy S....Roeder R.G. (1992)
214. A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. (PubMed id 1358756)⁹ Lai J.S....Herr W. (1992)
215. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. (PubMed id 1683003)⁹ Ullman K.S....Crabtree G.R. (1991)
216. Both Oct-1 and Oct-2A contain domains which can activate the ubiquitously expressed U2 snRNA genes. (PubMed id 1829677)⁹ Yang J....Pettersson U. (1991)
217. Role of alpha-transinducing factor (VP16) in the induction of alpha genes within the context of viral genomes. (PubMed id 1645782)⁹ Spector D....Roizman B. (1991)
218. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. (PubMed id 2302733)⁹ Tanaka M. and Herr W. (1990)
219. Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells. (PubMed id 18948549)⁹ Nakase K....Marasco W.A. (2009)
220. Glutamate-induced octamer DNA binding and transcriptional control in cultured radial glia cells. (PubMed id 16787415)⁹ Lopez-Bayghen E....Ortega A. (2006)
221. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors. (PubMed id 15325274)⁹ Zhao C....Tang H. (2004)
222. In silico and in situ characterization of the zebrafish (Danio rerio) gnrh3 (sGnRH) gene. (PubMed id 12188930)⁹ Torgersen J....AlestrAPm P. (2002)
223. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas. (PubMed id 11904338)⁹ Saez A.I....Piris M.A. (2002)
224. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. (PubMed id 11420680)⁹ Jin S....Zhan Q. (2001)
225. Octamer proteins inhibit IL-4 gene transcription in normal human CD4 T cells. (PubMed id 11781715)⁹ Cron R.Q....Lewis D.B. (2001)
226. Conservation of glutamine-rich transactivation function between yeast and humans. (PubMed id 10733580)⁹ Escher D....Schaffner W. (2000)
227. Examination of POU homeobox gene expression in human breast cancer cells. (PubMed id 10077160)⁹ Jin T....Goss P.E. (1999)
228. Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells. (PubMed id 10359895)⁹ Mordvinov V.A....Sanderson C.J. (1999)
229. Crystal structure of the conserved core of the herpes simplex virus transcriptional regulatory protein VP16. (PubMed id 10398682)⁹ Liu Y....Cheng X. (1999)
230. Oct-1 is involved in the transcriptional repression of the von willebrand factor gene promoter. (PubMed id 9694713)⁹ Schwachtgen J.L....Kerbiriou-Nabias D. (1998)
231. Oct-1 promoter region contains octamer sites and TAAT motifs recognized by Oct proteins. (PubMed id 9598983)⁹ Pankratova E.V....Polanovasky O.L. (1998)
232. Transcription factor NF-kappaB regulates inducible Oct-2 gene expression in precursor B lymphocytes. (PubMed id 9360945)⁹ Bendall H.H....Oltz E.M. (1997)
233. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia. (PubMed id 9422986)⁹ Hietala K.A....Kellokoski J.K. (1997)
234. Characterization of constitutive and inducible transcription factors binding to the P2 NF-AT site in the human interleukin-4 promoter. (PubMed id 9133600)⁹ Li-Weber M....Krammer P.H. (1997)
235. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. (PubMed id 8657574)⁹ Schubart D.B....Matthias P. (1996)
236. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. (PubMed id 8654375)⁹ Gstaiger M....Schaffner W. (1996)
237. Octamer independent activation of transcription from the kappa immunoglobulin germline promoter. (PubMed id 8972869)⁹ Prabhu A....Van Ness B. (1996)
238. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. (PubMed id 7623806)⁹ Luo Y. and Roeder R.G. (1995)
239. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor. (PubMed id 7931079)⁹ de Grazia U....Gulino A. (1994)
240. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter. (PubMed id 7680653)⁹ Thevenin C....Kehrl J.H. (1993)
241. The adenovirus terminal protein influences binding of replication proteins and changes the origin structure. (PubMed id 8506126)⁹ Pronk R. and van der Vliet P.C. (1993)
242. Differential expression of four members of the POU family of proteins in activated and phorbol 12-myristate 13-acetate-treated Jurkat T cells. (PubMed id 8234287)⁹ Bhargava A.K.... Weissman S.M. (1993)
243. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. (PubMed id 8357791)⁹ van Wijnen A.J....Stein G.S. (1993)
244. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins. (PubMed id 1346336)⁹ Verrijzer C.P....van der Vliet P.C. (1992)
245. Adenovirus DNA replication: the function of the covalently bound terminal protein. (PubMed id 1291241)⁹ Pronk R....van der Vliet P.C. (1992)
246. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. (PubMed id 1739980)⁹ Tanaka M.... Herr W. (1992)
247. Transcription factor requirements for U2 snRNA-encoding gene activation in B lymphoid cells. (PubMed id 1765275)⁹ Janson L. and Pettersson U. (1991)
248. The DNA binding domain (POU domain) of transcription factor oct-1 suffices for stimulation of DNA replication. (PubMed id 2347308)⁹ Verrijzer C.P....Van der Vliet P.C. (1990)
249. Genomic organization and regulation of the human orex in (hypocretin) receptor 2 gene: identification of alternative promoters. (PubMed id 20156195)⁹ Chen J. and Randeva H.S. (2010)
250. Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. (PubMed id 19224997)⁹ Di Bartolo D.L....Cesarman E. (2009)
251. Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells. (PubMed id 19212692)⁹ Lacal P.M....Graziani G. (2009)
252. The POU homeobox protein Oct-1 regulates radial glia formation downstream of Notch signaling. (PubMed id 18241856)⁹ Kiyota T....Kato Y. (2008)
253. Transcriptional regulatory network analysis during epithelial-mesenchymal transformation of retinal pigment epithelium. (PubMed id 18682805)⁹ Pratt C.H....Grunwald G.B. (2008)
254. Cadmium, cobalt and lead cause stress response, cell cycle deregulation and increased steroid as well as xenobiotic metabolism in primary normal human bronchial epithelial cells which is coordinated by at least nine transcription factors. (PubMed id 18654764)⁹ Glahn F....Foth H. (2008)
255. PPARalpha and AP-2alpha regulate bombesin receptor subtype 3 expression in ozone-stressed bronchial epithelial cells. (PubMed id 17355223)⁹ Tan Y.R....Weber H.C. (2007)
256. Understanding the mechanisms of zinc-sensing by metal -response element binding transcription factor-1 (MTF-1). (PubMed id 17462582)⁹ Laity J.H. and Andrews G.K. (2007)
257. Impaired binding of AHSP to alpha chain variants: Hb Groene Hart illustrates a mechanism leading to unstable hemoglobins with alpha thalassemic like syndrome. (PubMed id 17052927)⁹ Vasseur-Godbillon C....Baudin-Creuza V. (2006)
258. Molecular mechanism of allergy-related gene regulation and hematopoietic cell development by transcription factors. (PubMed id 16428815)⁹ Nishiyama C. (2006)
259. B29 gene silencing in pituitary cells is regulated by its 3' enhancer. (PubMed id 16920149)⁹ Malone C.S....Wall R. (2006)
260. Identification of transcriptional regulators of neuropeptide FF gene expression. (PubMed id 16515822)⁹ Nystedt J.M....Panula P. (2006)
261. The transcription factor PLA-1/SKN-1A is expressed in human placenta and regulates the placental lactogen-3 gene expression. (PubMed id 16005513)⁹ Jimenez-Mateo O....Castrillo J.L. (2006)
262. Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. (PubMed id 16754848)⁹ Tuo J.... Chan C.-C. (2006)
263. Molecular characterization of the Japanese flounder, Paralichthys olivaceus, CD3epsilon and evolution of the CD3 cluster. (PubMed id 15450752)⁹ Park C.I....Aoki T. (2005)
264. Characterization of two genes encoding leucine-rich repeat-containing proteins in grass carp Ctenopharyngodon idellus. (PubMed id 15578176)⁹ Chang M.X....Gao Q. (2005)
265. STAT4 expression in human T cells is regulated by DNA methylation but not by promoter polymorphism. (PubMed id 16301617)⁹ Shin H.J....Lee C.W. (2005)
266. Functional characterization of the sea urchin sns chromatin insulator in erythroid cells. (PubMed id 16185901)⁹ Acuto S....Spinelli G. (2005)
267. Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. (PubMed id 16061936)⁹ Goffin V....Van Lint C. (2005)
268. The protein kinase C pathway acts through multiple transcription factors to repress gonadotropin-releasing hormone gene expression in hypothalamic GT1-7 neuronal cells. (PubMed id 15994198)⁹ Tang Q....Mellon P.L. (2005)
269. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region. (PubMed id 16002244)⁹ Romanelli M.G....Morandi C. (2005)
270. The neuronal host cell factor-binding protein Zhangfei inhibits herpes simplex virus replication. (PubMed id 16282471)⁹ Akhova O....Misra V. (2005)
271. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line. (PubMed id 16179863)⁹ Zhu B.K. and Pruitt S.C. (2005)
272. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. (PubMed id 14630700)⁹ Mackenzie G.G....Oteiza P.I. (2004)
273. Repression of gonadotropin-releasing hormone (GnRH) gene expression by melatonin may involve transcription factors COUP-TFI and C/EBP beta binding at the GnRH enhancer. (PubMed id 15004428)⁹ Gillespie J.M....Belsham D.D. (2004)
274. A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression. (PubMed id 14993281)⁹ Wang J. and Yen A. (2004)
275. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. (PubMed id 14707079)⁹ Sepulveda M.A....Birshtein B.K. (2004)
276. Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. (PubMed id 15336700)⁹ Tynan S.H....Allan G.F. (2004)
277. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines. (PubMed id 12584750)⁹ Wang W....Cassidy J. (2003)
278. Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells. (PubMed id 12783878)⁹ Corti C....Ferraguti F. (2003)
279. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. (PubMed id 12881480)⁹ Bruemmer D....Law R.E. (2003)
280. Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. (PubMed id 12757776)⁹ Hube F.... Gruel Y. (2003)
281. Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3. (PubMed id 12752447)⁹ Liu M....Levy G.A. (2003)
282. Cloning of a protein binding to the most proximal Pit-1 binding element of prolactin gene from human pituitary cDNA library. (PubMed id 12972181)⁹ Fumoto M....Chihara K. (2003)
283. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. (PubMed id 12650610)⁹ Denhardt D.T....Rittling S.R. (2003)
284. Nitrosative stress and transcription. (PubMed id 14669980)⁹ KrAPncke K.D. (2003)
285. Cloning and characterization of the chick Oct binding factor OBF-1. (PubMed id 12359338)⁹ Takechi S....Nakayama T. (2002)
286. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. (PubMed id 11895773)⁹ Peng Y. and Jahroudi N. (2002)
287. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. (PubMed id 11937630)⁹ Shore P....Corcoran L.M. (2002)
288. Structural and functional characterization of the human PAX7 5'-flanking regulatory region. (PubMed id 12234688)⁹ Syagailo Y.V....Lesch K.P. (2002)
289. Analysis of the promoter region of human mimecan gene. (PubMed id 12020827)⁹ Tasheva E.S. (2002)
290. An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP. (PubMed id 12271126)⁹ Luciano R.L. and Wilson A.C. (2002)
291. Stabilization but not the transcriptional activity of herpes simplex virus VP16-induced complexes is evolutionarily conserved among HCF family members. (PubMed id 11711630)⁹ Lee S. and Herr W. (2001)
292. Human ribonucleotide reductase M2 subunit gene amplification and transcriptional regulation in a homogeneous staining chromosome region responsible for the mechanism of drug resistance. (PubMed id 11978967)⁹ Zhou B....Yen Y. (2001)
293. Inhibition of LZIP-mediated transcription through direct interaction with a novel host cell factor-like protein. (PubMed id 11384994)⁹ Zhou H.-J....Jin D.-Y. (2001)
294. Transcriptional regulation of galectin-10 (eosinophil Charcot-Leyden crystal protein): a GC box (-44 to -50) controls butyric acid induction of gene expression. (PubMed id 11441910)⁹ Dyer K.D. and Rosenberg H.F. (2001)
295. The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene. (PubMed id 11375392)⁹ Rundlof A.K....Arner E.S. (2001)
296. Genomic organization and transcription units of the human acyl-CoA synthetase 3 gene. (PubMed id 11707336)⁹ Minekura H....Yamamoto T.T. (2001)
297. Cellular transcription factors that interact with p6 promoter elements of parvovirus B19. (PubMed id 11369893)⁹ Raab U....Modrow S. (2001)
298. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. (PubMed id 11533238)⁹ Osborne A....Blanck G. (2001)
299. Novel control motif cluster in the IgH delta-gamma 3 interval exhibits B cell-specific enhancer function in early development. (PubMed id 11207287)⁹ Mundt C.A....Bruggemann M. (2001)
300. Transcriptional regulation of IL-5 gene by nontransformed human T cells through the proximal promoter element. (PubMed id 10939534)⁹ Mori A....Akiyama K. (2000)
301. Specific interaction of TAFII105 with OCA-B is involved in activation of octamer-dependent transcription. (PubMed id 10828057)⁹ Wolstein O.... Dikstein R. (2000)
302. Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. (PubMed id 10623541)⁹ Turgeon D....Hum D.W. (2000)
303. Transcription factors Oct-1 and C/EBPbeta (CCAAT/enhancer-binding protein-beta) are involved in the glutamate/nitric oxide/cyclic-guanosine 5'-monophosphate-mediated repression of mediated repression of gonadotropin-releasing hormone gene expression. (PubMed id 10674395)⁹ Belsham D.D. and Mellon P.L. (2000)
304. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1. (PubMed id 10604987)⁹ Schubart D.B....Matthias P. (2000)
305. In vivo protein-DNA interactions at the kinin B(1) receptor gene promoter: no modification on interleukin-1 beta or lipopolysaccharide induction. (PubMed id 10842322)⁹ Angers M....Bachvarov D.R. (2000)
306. Identification of cis-acting DNA elements required for expression of the human cardiac troponin I gene promoter. (PubMed id 10652194)⁹ Bhavsar P.K....Barton P.J. (2000)
307. Activation of the transcription factor Oct-1 in response to DNA damage. (PubMed id 11103783)⁹ Zhao H....Zhan Q. (2000)
308. Ku autoantigen: a multifunctional DNA-binding protein. (PubMed id 10755664)⁹ Tuteja R. and Tuteja N. (2000)
309. Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: applications for cardiovascular gene therapy. (PubMed id 10609662)⁹ Houston P....Braddock M. (1999)
310. Oct-1 POU and octamer DNA co-operate to recognise the Bob-1 transcription co-activator via induced folding. (PubMed id 10329190)⁹ Chang J.F....Luisi B. (1999)
311. Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. (PubMed id 10233965)⁹ Zhao W....Broker T.R. (1999)
312. POU family transcription factors in the nervous system. (PubMed id 10199551)⁹ Latchman D.S. (1999)
313. Mechanism of DNA replication in eukaryotic cells: cellular host factors stimulating adenovirus DNA replication. (PubMed id 10433960)⁹ de Jong R.N. and van der Vliet P.C. (1999)
314. Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells. (PubMed id 10544969)⁹ Meighan-Mantha R.L....Kasid U. (1999)
315. [Functional analysis of human A gamma-globin gene promoter with-173 T-->C mutation] (PubMed id 12567445)⁹ Huang X....Zhao H. (1999)
316. The activity of the human interleukin-5 conserved lymphokine element 0 is regulated by octamer factors in human cells. (PubMed id 10491186)⁹ Thomas M.A....Sanderson C.J. (1999)
317. Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis. (PubMed id 9797555)⁹ Wakisaka S....Sakane T. (1998)
318. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells. (PubMed id 9823429)⁹ Singh S....Aggarwal B.B. (1998)
319. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells. (PubMed id 9710582)⁹ Chang J.H....Burakoff S.J. (1998)
320. Five discrete cis-active domains direct cell type-specific transcription of the vasoactive intestinal peptide (VIP) gene. (PubMed id 9642274)⁹ Hahm S.H. and Eiden L.E. (1998)
321. Identification of conserved potentially regulatory sequences of the SRY gene from 10 different species of mammals. (PubMed id 9571157)⁹ Margarit E....Oliva R. (1998)
322. MSG1 (melanocyte-specific gene 1): mapping to chromos ome Xq13.1, genomic organization, and promoter analysis. (PubMed id 9721210)⁹ Fenner M.H....Shioda T. (1998)
323. GATA-1 DNA binding activity is down-regulated in late S phase in erythroid cells. (PubMed id 8999960)⁹ Cullen M.E. and Patient R.K. (1997)
324. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat. (PubMed id 9078256)⁹ Liu Y.Z. and Latchman D.S. (1997)
325. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB. (PubMed id 9348104)⁹ Lyss G....Pahl H.L. (1997)
326. Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1beta gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1. (PubMed id 9376596)⁹ Tsukada J....Eto S. (1997)
327. Identification of cis-regulatory elements in the upstream regulatory region of human papillomavirus type 59. (PubMed id 9085547)⁹ Rho J....Choe J. (1997)
328. Characterization of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression. (PubMed id 9188490)⁹ Andersen B....Rosenfeld M.G. (1997)
329. Reversible activation of mouse metal response element-binding transcription factor 1 DNA binding involves zinc interaction with the zinc finger domain. (PubMed id 9111349)⁹ Dalton T.P....Andrews G.K. (1997)
330. Cysteine 50 of the POU H domain determines the range of targets recognized by POU proteins. (PubMed id 9207034)⁹ Stepchenko A.G....Pankratova E.V. (1997)
331. Mutation in an alpha1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors. (PubMed id 9434101)⁹ Morgan K....Kalsheker N.A. (1997)
332. Proteasome regulation of Fas ligand cytotoxicity. (PubMed id 9341769)⁹ Matsui K....Ju S.T. (1997)
333. VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. (PubMed id 9315674)⁹ Wilson A.C....Herr W. (1997)
334. Transcriptional regulation of the human replacement histone gene H3.3B. (PubMed id 9188772)⁹ Witt O....Doenecke D. (1997)
335. Effects of oxidation and reduction on the binding of transcription factors to cis-regulatory elements located in the FGF-4 gene. (PubMed id 9115711)⁹ Lickteig K....Rizzino A. (1996)
336. Assignment of the human gene for Oct-binding factor-1 (OBF1), a B-cell-specific coactivator of octamer-binding transcription factors 1 and 2, to 11q23.1 by somatic cell hybridization and in situ hybridization. (PubMed id 8617501)⁹ Junker S....Tommerup N. (1996)
337. Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif. (PubMed id 8964085)⁹ Felli M.P....Gulino A. (1996)
338. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. (PubMed id 8668543)⁹ Vigano M.A. and Staudt L.M. (1996)
339. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. (PubMed id 8769650)⁹ Cepek K.L....Sharp P.A. (1996)
340. Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor. (PubMed id 8733011)⁹ Gottlicher M....Herrlich P. (1996)
341. Structure, organization, and transcription units of the human alpha- platelet-derived growth factor receptor gene, PDGFRA. (PubMed id 8586421)⁹ Kawagishi J. and Ku T. (1995)
342. M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding. (PubMed id 8524234)⁹ Caelles C....Karin M. (1995)
343. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. (PubMed id 7721885)⁹ Wang P....Billah M.M. (1995)
344. Phosphorylation of transcription factors and control of the cell cycle. (PubMed id 7549180)⁹ Boulikas T. (1995)
345. Involvement of the Ets family factor PU.1 in the acti vation of immunoglobulin promoters. (PubMed id 7822329)⁹ Schwarzenbach H....Matthias P. (1995)
346. Down regulation of the octamer binding protein Oct-1 during growth arrest and differentiation of a neuronal cell line. (PubMed id 7707877)⁹ Lakin N.D....Latchman D.S. (1995)
347. Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-kappa B p50-p50 for the anti-apoptotic function of Bcl-2. (PubMed id 8580069)⁹ Ivanov V.N....Malek T.R. (1995)
348. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. (PubMed id 7645210)⁹ Kyo S....Laimins L.A. (1995)
349. The C-terminus of the B cell activator Oct-2 functions as an activation domain in yeast. (PubMed id 7811293)⁹ Mead J....Ludmerer S.W. (1994)
350. Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex. (PubMed id 8035517)⁹ Lukac D.M....Alwine J.C. (1994)
351. Assembly and DNA binding of recombinant Ku (p70/p80) autoantigen defined by a novel monoclonal antibody specific for p70/p80 heterodimers. (PubMed id 7699019)⁹ Wang J....Reeves W.H. (1994)
352. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription. (PubMed id 8065338)⁹ Tanaka M....Herr W. (1994)
353. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors. (PubMed id 7708050)⁹ Liu M. and Freedman L.P. (1994)
354. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. (PubMed id 8083999)⁹ Ushikai M....Davidson I. (1994)
355. A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell lines. (PubMed id 8026890)⁹ Thomson J.A....Parsons P.G. (1994)
356. Control of DNA replication by protein phosphorylation. (PubMed id 7872668)⁹ Boulikas T. (1994)
357. Gene transcription in differentiating immature T cell receptor(neg) thymocytes resembles antigen-activated mature T cells. (PubMed id 8376926)⁹ ZA_A+iga-PflA1cker J.C....Lenardo M.J. (1993)
358. Specific cleavage of transcription factors by the thiol protease, m-calpain. (PubMed id 8255762)⁹ Watt F. and Molloy P.L. (1993)
359. Chromosomal organization of the gene encoding porcine antileukoproteinase and functional analysis of the promoter region in endometrial and placental cells. (PubMed id 7908270)⁹ Simmen R.C....Michel F.J. (1993)
360. Specific transcriptional activation in vitro by the herpes simplex virus protein VP16. (PubMed id 8284200)⁹ Arnosti D.N....Luisi B.F. (1993)
361. Molecular basis for developmental changes in interleukin-2 gene inducibility. (PubMed id 8417328)⁹ Chen D. and Rothenberg E.V. (1993)
362. Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions. (PubMed id 1464321)⁹ Seipel K....Schaffner W. (1992)
363. Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. (PubMed id 1406672)⁹ Kutoh E....Poellinger L. (1992)
364. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. (PubMed id 1534100)⁹ Christensen S.M....Weis J.H. (1992)
365. A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells. (PubMed id 1383937)⁹ Lillycrop K.A....Latchman D.S. (1992)
366. The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity. (PubMed id 1614851)⁹ Hentsch B....Serfling E. (1992)
367. Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. (PubMed id 1495986)⁹ Lai J.S. and Herr W. (1992)
368. Okadaic acid is a potent inducer of AP-1, NF-kappa B, and tumor necrosis factor-alpha in human B lymphocytes. (PubMed id 1520341)⁹ Rieckmann P....Kehrl J.H. (1992)
369. Recognition of the surface of a homeo domain protein. (PubMed id 1358755)⁹ Pomerantz J.L....Sharp P.A. (1992)
370. POU proteins bend DNA via the POU-specific domain. (PubMed id 1915275)⁹ Verrijzer C.P....van der Vliet P.C. (1991)
371. Differentiation of human B-cell malignant lymphomas is independent of the octamer lymphoid specific binding factor (Oct-2). (PubMed id 1937571)⁹ Kossakowska A.E. and Urbanski S.J. (1991)
372. Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration. (PubMed id 2014164)⁹ Kemler I....Schaffner W. (1991)
373. Nuclear transcription factors that bind to elements of the IL-2 promoter. Induction requirements in primary human T cells. (PubMed id 1655897)⁹ Granelli-Piperno A. and Nolan P. (1991)

External Searches for POU2F1 gene

Genome Databases showing POU2F1 gene

Other Databases showing POU2F1 gene

Specialized Databases showing POU2F1 gene

Products
for POU2F1 gene